1.       Blanchard AC, Waters V. Opportunistic pathogens in cystic fibrosis: epidemiology and pathogenesis of lung infection. J Pediatric Infect Dis Soc. 2022;11(Suppl 2):S3–S12. doi:10.1093/jpids/piac052

2.       Bonnet P, Le Gal S, Calderon E, et al. Pneumocystis jirovecii in patients with cystic fibrosis: a review. Front Cell Infect Microbiol. 2020;10:571253. doi:10.3389/fcimb.2020.571253

3.       Buruiană G, Sima CM, Anton-Păduraru DT, et al. Airway microbiome in children with cystic fibrosis: a review of microbial shifts and therapeutic impacts. Medicina (Kaunas). 2025;61:1605. doi:10.3390/medicina61091605

4.       Cystic Fibrosis Foundation. Clinical care guidelines for cystic fibrosis. Bethesda (MD): Cystic Fibrosis Foundation; 2023.

5.       Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180(9):802-808. doi:10.1164/rccm.200812-1845PP

6.       Kartal Öztürk G, Eşki A, Çelebi Çelik F, ve ark. Prospective evaluation of vascular changes in acute respiratory infections in children with cystic fibrosis. Turk J Med Sci. 2020;50(4):1007-1014. doi:10.3906/sag-2002-61

7.       Royal Brompton Hospital. Clinical guidelines: care of children with cystic fibrosis. 9th ed. London: Royal Brompton Hospital; 2023.

8.       Shmarina G, Pukhalskaya D, Shmarin V, et al. Burkholderia cepacia in cystic fibrosis children and adolescents: overall survival and immune alterations. Front Cell Infect Microbiol. 2024;14:1374318. doi:10.3389/fcimb.2024.1374318

9.       Taccetti G, Terlizzi V, Campana S, et al. Antibiotic treatment of bacterial lung infections in cystic fibrosis. Eur J Pediatr. 2025;184:82. doi:10.1007/s00431-024-05905-9

10.   Thornton CS, Parkins MD. Microbial epidemiology and emerging pathogens in cystic fibrosis. Clin Microbiol Rev. 2023;36:e0002022.

11.   Türk Toraks Derneği. Kistik Fibrozis Tanı ve Tedavi Rehberi. Ankara: Türk Toraks Derneği Yayınları; 2023.

12.   Veschetti L, Boaretti M, Saitta GM, et al. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection. Microbiol Res. 2022;263:127140. doi:10.1016/j.micres.2022.127140